1. RiveraCM, RenB (2013) Mapping human epigenomes. Cell 155: 39–55.
2. BarskiA, CuddapahS, CuiK, RohTY, SchonesDE, et al. (2007) High-resolution profiling of histone methylations in the human genome. Cell 129: 823–837.
3. YuBD, HessJL, HorningSE, BrownGA, KorsmeyerSJ (1995) Altered Hox expression and segmental identity in Mll-mutant mice. Nature 378: 505–508.
4. GlaserS, MetcalfD, WuL, HartAH, DiRagoL, et al. (2006) Enforced expression of the homeobox gene Mixl1 impairs hematopoietic differentiation and results in acute myeloid leukemia. Proc Natl Acad Sci U S A 103: 16460–16465.
5. LubitzS, GlaserS, SchaftJ, StewartAF, AnastassiadisK (2007) Increased apoptosis and skewed differentiation in mouse embryonic stem cells lacking the histone methyltransferase Mll2. Molecular biology of the cell 18: 2356–2366.
6. DouY, MilneTA, RuthenburgAJ, LeeS, LeeJW, et al. (2006) Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat Struct Mol Biol 13: 713–719.
7. StewardMM, LeeJS, O'DonovanA, WyattM, BernsteinBE, et al. (2006) Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes. Nat Struct Mol Biol 13: 852–854.
8. DemersC, ChaturvediCP, RanishJA, JubanG, LaiP, et al. (2007) Activator-mediated recruitment of the MLL2 methyltransferase complex to the beta-globin locus. Molecular Cell 27: 573–584.
9. RampalliS, LiL, MakE, GeK, BrandM, et al. (2007) p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation. Nat Struct Mol Biol 14: 1150–1156.
10. LiX, WangS, LiY, DengC, SteinerLA, et al. (2011) Chromatin boundaries require functional collaboration between the hSET1 and NURF complexes. Blood 118: 1386–1394.
11. TyagiS, ChabesAL, WysockaJ, HerrW (2007) E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. Molecular Cell 27: 107–119.
12. KnipeDM, LiebermanPM, JungJU, McBrideAA, MorrisKV, et al. (2013) Snapshots: chromatin control of viral infection. Virology 435: 141–156.
13. WysockaJ, MyersMP, LahertyCD, EisenmanRN, HerrW (2003) Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1. Genes & Development 17: 896–911.
14. GrundhoffA, GanemD (2004) Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 113: 124–136.
15. DittmerDP, DamaniaB (2013) Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)–an update. Current opinion in virology 3: 238–244.
16. SpeckSH, GanemD (2010) Viral latency and its regulation: lessons from the gamma-herpesviruses. Cell Host Microbe 8: 100–115.
17. BallestasME, ChatisPA, KayeKM (1999) Efficient persistence of extrachromosomal KSHV DNA mediated by latency- associated nuclear antigen. Science 284: 641–644.
18. BarberaAJ, ChodaparambilJV, Kelley-ClarkeB, JoukovV, WalterJC, et al. (2006) The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science 311: 856–861.
19. CotterMA2nd, RobertsonES (1999) The latency-associated nuclear antigen tethers the Kaposi's sarcoma- associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells [In Process Citation]. Virology 264: 254–264.
20. GarberAC, HuJ, RenneR (2002) Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication. J Biol Chem 277: 27401–27411.
21. HuJ, GarberAC, RenneR (2002) The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J Virol 76: 11677–11687.
22. KimKY, HuertaSB, IzumiyaC, WangDH, MartinezA, et al. (2013) Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A. J Virol 87: 6782–6793.
23. SakakibaraS, UedaK, NishimuraK, DoE, OhsakiE, et al. (2004) Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen. J Virol 78: 7299–7310.
24. KrithivasA, YoungDB, LiaoG, GreeneD, HaywardSD (2000) Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J Virol 74: 9637–9645.
25. LimC, GwackY, HwangS, KimS, ChoeJ (2001) The transcriptional activity of cAMP response element-binding protein- binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Biol Chem 276: 31016–31022.
26. JeongJH, OrvisJ, KimJW, McMurtreyCP, RenneR, et al. (2004) Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Biol Chem 279: 16822–16831.
27. OttingerM, ChristallaT, NathanK, BrinkmannMM, Viejo-BorbollaA, et al. (2006) Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest. J Virol 80: 10772–10786.
28. PlattGM, SimpsonGR, MittnachtS, SchulzTF (1999) Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the drosophila female sterile homeotic (fsh) gene [In Process Citation]. J Virol 73: 9789–9795.
29. Viejo-BorbollaA, OttingerM, BruningE, BurgerA, KonigR, et al. (2005) Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. J Virol 79: 13618–13629.
30. LimC, LeeD, SeoT, ChoiC, ChoeJ (2003) Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus functionally interacts with heterochromatin protein 1. J Biol Chem 278: 7397–7405.
31. ShamayM, KrithivasA, ZhangJ, HaywardSD (2006) Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA. Proc Natl Acad Sci U S A 103: 14554–14559.
32. HuJ, LiuE, RenneR (2009) Involvement of SSRP1 in latent replication of Kaposi's sarcoma-associated herpesvirus. J Virol 83: 11051–11063.
33. BallestasME, KayeKM (2011) The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency. Future microbiology 6: 1399–1413.
34. GuntherT, GrundhoffA The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog 6: e1000935.
35. TothZ, MaglinteDT, LeeSH, LeeHR, WongLY, et al. (2010) Epigenetic analysis of KSHV latent and lytic genomes. PLoS pathogens 6: e1001013.
36. StedmanW, KangH, LinS, KissilJL, BartolomeiMS, et al. (2008) Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators. Embo J 27: 654–666.
37. TemperaI, LiebermanPM (2010) Chromatin organization of gammaherpesvirus latent genomes. Biochim Biophys Acta 1799: 236–245.
38. LangmeadB (2010) Aligning short sequencing reads with Bowtie. Curr Protoc Bioinformatics Chapter 11: Unit 11 17.
39. BlandJM (1986) Computer simulation of a clinical trial as an aid to teaching the concept of statistical significance. Statistics in medicine 5: 193–197.
40. BlandJM, AltmanDG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307–310.
41. DudoitS, FridlyandJ (2002) A prediction-based resampling method for estimating the number of clusters in a dataset. Genome Biology 3 doi:10.1186
42. McIntyreLM, LopianoKK, MorseAM, AminV, ObergAL, et al. (2011) RNA-seq: technical variability and sampling. BMC genomics 12: 293.
43. JiH, JiangH, MaW, JohnsonDS, MyersRM, et al. (2008) An integrated software system for analyzing ChIP-chip and ChIP-seq data. Nature biotechnology 26: 1293–1300.
44. DittmerD, LagunoffM, RenneR, StaskusK, HaaseA, et al. (1998) A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol 72: 8309–8315.
45. PearceM, MatsumuraS, WilsonAC (2005) Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter. J Virol 79: 14457–14464.
46. ChengB, LiT, RahlPB, AdamsonTE, LoudasNB, et al. (2012) Functional association of Gdown1 with RNA polymerase II poised on human genes. Molecular cell 45: 38–50.
47. FengW, LiuY, WuJ, NephewKP, HuangTH, et al. (2008) A Poisson mixture model to identify changes in RNA polymerase II binding quantity using high-throughput sequencing technology. BMC genomics 9 Suppl 2: S23.
48. GuF, HsuHK, HsuPY, WuJ, MaY, et al. (2010) Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data. BMC systems biology 4: 170.
49. DarstRP, HaeckerI, PardoCE, RenneR, KladdeMP (2013) Epigenetic diversity of Kaposi's sarcoma-associated herpesvirus. Nucleic Acids Res 41: 2993–3009.
50. ChandrianiS, GanemD (2010) Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus. J Virol 84: 5565–5573.
51. TothZ, BruloisKF, WongLY, LeeHR, ChungB, et al. (2012) Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression. J Virol 86: 9696–9707.
52. ChenW, SinSH, WenKW, DamaniaB, DittmerDP (2012) Hsp90 inhibitors are efficacious against Kaposi Sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteins. PLoS pathogens 8: e1003048.
53. AnFQ, FolarinHM, CompitelloN, RothJ, GersonSL, et al. (2006) Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo. J Virol 80: 4833–4846.
54. LiebermanPM (2013) Keeping it quiet: chromatin control of gammaherpesvirus latency. Nature reviews Microbiology 11: 863–875.
55. TothZ, BruloisK, JungJU (2013) The chromatin landscape of Kaposi's sarcoma-associated herpesvirus. Viruses 5: 1346–1373.
56. HuJ, RenneR (2005) Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin. J Virol 79: 2637–2642.
57. RenneR, BarryC, DittmerD, CompitelloN, BrownPO, et al. (2001) Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol 75: 458–468.
58. LuF, TsaiK, ChenHS, WikramasingheP, DavuluriRV, et al. (2012) Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA. J Virol 86: 5752–5762.
59. JeongJ, PapinJ, DittmerD (2001) Differential Regulation of the Overlapping Kaposi's Sarcoma-Associated Herpesvirus vGCR (orf74) and LANA (orf73) Promoters. J Virol 75: 1798–1807.
60. KangH, ChoH, SungGH, LiebermanPM (2013) CTCF regulates Kaposi's sarcoma-associated herpesvirus latency transcription by nucleosome displacement and RNA polymerase programming. J Virol 87: 1789–1799.
61. ChenHS, WikramasingheP, ShoweL, LiebermanPM (2012) Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency. J Virol 86: 9454–9464.
62. LanK, KuppersDA, VermaSC, SharmaN, MurakamiM, et al. (2005) Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency. J Virol 79: 7453–7465.
63. LiangY, ChangJ, LynchSJ, LukacDM, GanemD (2002) The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev 16: 1977–1989.
64. RossettoC, YambolievI, PariGS (2009) Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 K-bZIP modulates latency-associated nuclear protein-mediated suppression of lytic origin-dependent DNA synthesis. J Virol 83: 8492–8501.
65. BallestasME, KayeKM (2001) Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. J Virol 75: 3250–3258.
66. TangJ, GordonGM, MullerMG, DahiyaM, ForemanKE (2003) Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces expression of the helix-loop-helix protein Id-1 in human endothelial cells. J Virol 77: 5975–5984.
67. LuJ, VermaSC, MurakamiM, CaiQ, KumarP, et al. (2009) Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation. J Virol 83: 7129–7141.
68. NojimaH, AdachiM, MatsuiT, OkawaK, TsukitaS (2008) IQGAP3 regulates cell proliferation through the Ras/ERK signalling cascade. Nature cell biology 10: 971–978.
69. Thomas-ChollierM, DarboE, HerrmannC, DefranceM, ThieffryD, et al. (2012) A complete workflow for the analysis of full-size ChIP-seq (and similar) data sets using peak-motifs. Nature protocols 7: 1551–1568.
70. Thomas-ChollierM, HerrmannC, DefranceM, SandO, ThieffryD, et al. (2012) RSAT peak-motifs: motif analysis in full-size ChIP-seq datasets. Nucleic Acids Res 40: e31.
71. BernsteinBE, BirneyE, DunhamI, GreenED, GunterC, et al. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489: 57–74.
72. AvalleL, PensaS, RegisG, NovelliF, PoliV (2012) STAT1 and STAT3 in tumorigenesis: A matter of balance. JAK-STAT 1: 65–72.
73. JennerRG, AlbaMM, BoshoffC, KellamP (2001) Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol 75: 891–902.
74. AnFQ, CompitelloN, HorwitzE, SramkoskiM, KnudsenES, et al. (2005) The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest. J Biol Chem 280: 3862–3874.
75. TothZ, BruloisK, LeeHR, IzumiyaY, TepperC, et al. (2013) Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection. PLoS pathogens 9: e1003813.
76. HiltonIB, SimonJM, LiebJD, DavisIJ, DamaniaB, et al. (2013) The Open Chromatin Landscape of Kaposi's Sarcoma-Associated Herpesvirus. J Virol 87: 11831–11842.
77. Thomas-ChollierM, DefranceM, Medina-RiveraA, SandO, HerrmannC, et al. (2011) RSAT 2011: regulatory sequence analysis tools. Nucleic Acids Res 39: W86–91.
78. Kelley-ClarkeB, De Leon-VazquezE, SlainK, BarberaAJ, KayeKM (2009) Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence. J Virol 83: 4326–4337.
79. Vazquez EdeL, CareyVJ, KayeKM (2013) Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence. J Virol 87: 12270–12283.
80. WongLY, MatchettGA, WilsonAC (2004) Transcriptional activation by the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen is facilitated by an N-terminal chromatin-binding motif. J Virol 78: 10074–10085.
81. MercierA, AriasC, MadridAS, HoldorfMM, GanemD (2014) Site-specific association with host and viral chromatin by KSHV LANA and its reversal during lytic replication. Journal of Virology doi: 10.1128
82. ChangHH, GanemD (2013) A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity. Cell Host & Microbe 13: 429–440.
83. YuanW, WuT, FuH, DaiC, WuH, et al. (2012) Dense chromatin activates Polycomb repressive complex 2 to regulate H3 lysine 27 methylation. Science 337: 971–975.
84. KrishnanHH, NaranattPP, SmithMS, ZengL, BloomerC, et al. (2004) Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J Virol 78: 3601–3620.
85. KangH, WiedmerA, YuanY, RobertsonE, LiebermanPM (2011) Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation. PLoS Pathogens 7: e1002140.
86. LangmeadB, TrapnellC, PopM, SalzbergSL (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
87. EdgarR, DomrachevM, LashAE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207–210.
88. MortazaviA, WilliamsBA, McCueK, SchaefferL, WoldB (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621–628.
89. BlandJM, AltmanDG (1988) Misleading statistics: errors in textbooks, software and manuals. International Journal of Epidemiology 17: 245–247.
90. BlandJM, AltmanDJ (1986) Regression analysis. Lancet 1: 908–909.
91. LandtSG, MarinovGK, KundajeA, KheradpourP, PauliF, et al. (2012) ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res 22: 1813–1831.
92. RiceP, LongdenI, BleasbyA (2000) EMBOSS: the European Molecular Biology Open Software Suite. Trends in Genetics : TIG 16: 276–277.
93. QuinlanAR, HallIM (2010) BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26: 841–842.
94. YeT, KrebsAR, ChoukrallahMA, KeimeC, PlewniakF, et al. (2011) seqMINER: an integrated ChIP-seq data interpretation platform. Nucleic Acids Res 39: e35.
95. LiY, DengC, HuX, PatelB, FuX, et al. (2012) Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis. Oncogene 31: 5007–5018.